false000178175500017817552024-11-042024-11-04

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________
FORM 8-K
______________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 4, 2024
______________________________
The Baldwin Insurance Group, Inc.
(Exact name of registrant as specified in its charter)
______________________________
Delaware001-3909561-1937225
(State or other jurisdiction of(Commission(I.R.S. Employer
incorporation or organization)File No.)Identification No.)
4211 W. Boy Scout Blvd., Suite 800, Tampa, Florida 33607
(Address of principal executive offices) (Zip code)
(Registrant's telephone number, including area code): (866) 279-0698
Not Applicable
(Former Name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Class A Common Stock, par value $0.01 per shareBWINNasdaq Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 2.02 Results of Operations and Financial Condition.

On November 4, 2024, The Baldwin Insurance Group, Inc. issued a press release announcing its financial results for the quarter ended September 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Current Report on Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits
Exhibit No.Description
99.1 
104 Cover Page Interactive Data File (embedded within the inline XBRL document)



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
The Baldwin Insurance Group, Inc.
Date: November 4, 2024By:/s/ Bradford L. Hale
  Name:Bradford L. Hale
  Title:Chief Financial Officer

Exhibit 99.1
tbglogohoriz-fullcolora.jpg
THE BALDWIN GROUP ANNOUNCES THIRD QUARTER 2024 RESULTS
- Total Revenue Growth of 11% to $338.9 Million; Organic Revenue Growth(1) of 14% -
- Net Loss of $14.5 Million and Diluted Loss Per Share of $0.13; Adjusted Diluted EPS(2) Growth of 14% to $0.33 -
- Adjusted EBITDA(3) Growth of 14% and Pro Forma Adjusted EBITDA(4) Growth of 18% Year-Over-Year to $72.8 Million and Adjusted EBITDA Margin(3) of 21%; 60 Basis Point Expansion Compared to the Prior-Year Period -
TAMPA, FLORIDA - November 4, 2024 - The Baldwin Group, the brand name for The Baldwin Insurance Group, Inc. (“Baldwin” or the “Company”) (NASDAQ: BWIN), an independent insurance distribution firm delivering tailored insurance solutions to a wide range of personal and commercial Clients, today announced its results for the third quarter ended September 30, 2024.
THIRD QUARTER 2024 HIGHLIGHTS
Total revenue increased 11% year-over-year to $338.9 million
Organic revenue growth of 14% year-over-year
GAAP net loss of $14.5 million and GAAP diluted loss per share of $0.13
Adjusted net income(2) of $38.5 million
Adjusted diluted EPS grew 14% year-over-year to $0.33
Adjusted EBITDA grew 14% year-over-year to $72.8 million
Adjusted EBITDA margin of 21.5%, a 60 basis point expansion compared to 20.9% in the prior-year period
Pro forma adjusted EBITDA grew 18% year-over-year to $72.8 million
“We delivered another strong quarter highlighting the resiliency of our business model in what has been an outstanding year for The Baldwin Group,” said Trevor Baldwin, Chief Executive Officer of The Baldwin Group. “We once again generated industry-leading double-digit organic growth and continued to expand our adjusted EBITDA margin and adjusted free cash flow, driven by a relentless focus on operational effectiveness and efficiency. Our team’s fantastic execution over the past couple years, along with our considerably stronger financial profile, has positioned us exceedingly well for sustained long-term growth and margin expansion.”
1



LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 2024, cash and cash equivalents were $181.8 million and the Company had $600.0 million of borrowing capacity under its revolving credit facility.
NINE MONTHS 2024 RESULTS
Revenue increased 13% year-over-year to $1.1 billion
Organic revenue growth of 16% year-over-year
GAAP net loss of $6.2 million and GAAP diluted loss per share of $0.07
Adjusted net income of $144.8 million
Adjusted diluted EPS grew 26% year-over-year to $1.23
Adjusted EBITDA grew 22% year-over-year to $249.3 million
Adjusted EBITDA margin of 23.5%, a 160 basis point expansion compared to 21.9% in the prior-year period
Pro forma adjusted EBITDA grew 24% year-over-year to $247.7 million
Net cash provided by operating activities of $85.7 million
Adjusted free cash flow(5) grew 31% year-over-year to $99.2 million
WEBCAST AND CONFERENCE CALL INFORMATION
Baldwin will host a webcast and conference call to discuss third quarter 2024 results today at 5:00 PM ET. A live webcast and a slide presentation of the conference call will be available on Baldwin’s investor relations website at ir.baldwin.com. The dial-in number for the conference call is (877) 451-6152 (toll-free) or (201) 389-0879 (international). Please dial the number 10 minutes prior to the scheduled start time.
A webcast replay of the call will be available at ir.baldwin.com for one year following the call.
ABOUT THE BALDWIN GROUP
The Baldwin Group, the brand name for The Baldwin Insurance Group, Inc. (NASDAQ: BWIN) and its affiliates, is an independent insurance distribution firm providing indispensable expertise and insights that strive to give our Clients the confidence to pursue their purpose, passion and dreams. As a team of dedicated entrepreneurs and insurance professionals, we have come together to help protect the possible for our Clients. We do this by delivering bespoke Client solutions, services, and innovation through our comprehensive and tailored approach to risk management, insurance, and employee benefits. We support our Clients, Colleagues, Insurance Company Partners, and communities through the deployment of vanguard resources and capital to drive our organic and inorganic growth. The Baldwin Group proudly represents more than two million Clients across the United States and internationally. For more information, please visit www.baldwin.com.
2



FOOTNOTES
(1)    Organic revenue for the three and nine months ended September 30, 2023 used to calculate organic revenue growth for the three and nine months ended September 30, 2024 was $294.5 million and $905.6 million, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2024. Organic revenue and organic revenue growth are non-GAAP measures. Reconciliation of organic revenue and organic revenue growth to commissions and fees, the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.
(2)    Adjusted net income and adjusted diluted EPS are non-GAAP measures. Reconciliation of adjusted net income to net loss attributable to Baldwin and reconciliation of adjusted diluted EPS to diluted loss per share, the most directly comparable GAAP financial measures, is set forth in the reconciliation table accompanying this release.
(3)    Adjusted EBITDA and adjusted EBITDA margin are non-GAAP measures. Reconciliation of adjusted EBITDA and adjusted EBITDA margin to net loss, the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.
(4)    Pro Forma Adjusted EBITDA is a non-GAAP measure. Reconciliation of Pro Forma Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.
(5)    Adjusted free cash flow is a non-GAAP measure. Reconciliation of adjusted free cash flow to net cash provided by operating activities, the most directly comparable GAAP financial measure, is set forth in the reconciliation table accompanying this release.
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This press release may contain various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Baldwin’s expectations or beliefs concerning future events. Forward-looking statements are statements other than historical facts and may include statements that address future operating, financial or business performance or Baldwin’s strategies or expectations. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential,” “outlook” or “continue,” or the negative of these terms or other comparable terminology. Forward-looking statements are based on management’s current expectations and beliefs and involve significant risks and uncertainties that could cause actual results, developments and business decisions to differ materially from those contemplated by these statements.
Factors that could cause actual results or performance to differ from the expectations expressed or implied in such forward-looking statements include, but are not limited to, those described under the caption “Risk Factors” in Baldwin’s Annual Report on Form 10-K for the year ended December 31, 2023 and in Baldwin’s other filings with the SEC, which are available free of charge on the SEC's website at: www.sec.gov, including those risks and other factors relevant to the business, financial condition and results of operations of Baldwin. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated. All forward-looking statements and all subsequent written and oral forward-looking statements attributable to Baldwin or to persons acting on behalf of Baldwin are expressly qualified in their entirety by reference to these risks and uncertainties. You should not place undue reliance on forward-looking statements. Forward-looking statements speak only as of the date they are made, and Baldwin does not undertake any obligation to update them in light of new information, future developments or otherwise, except as may be required under applicable law.
3



CONTACTS
MEDIA RELATIONS
Anna Rozenich, Senior Director, Enterprise Communications
The Baldwin Group
630.561.5907 | anna.rozenich@baldwin.com
INVESTOR RELATIONS
Bonnie Bishop, Executive Director, Investor Relations
The Baldwin Group
813.259.8032 | IR@baldwin.com

4



THE BALDWIN INSURANCE GROUP, INC.
Condensed Consolidated Statements of Comprehensive Loss
(Unaudited)
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except share and per share data)2024202320242023
Revenues:
Commissions and fees$335,210 $304,232 $1,050,409 $929,306 
Investment income3,728 2,038 8,736 4,601 
Total revenues338,938 306,270 1,059,145 933,907 
Operating expenses:
Commissions, employee compensation and benefits247,189 220,469 753,596 676,659 
Other operating expenses48,839 47,165 141,198 141,254 
Amortization expense26,899 23,183 76,334 69,505 
Change in fair value of contingent consideration(952)13,914 17,276 55,065 
Depreciation expense1,557 1,453 4,619 4,250 
Total operating expenses323,532 306,184 993,023 946,733 
Operating income (loss)15,406 86 66,122 (12,826)
Other income (expense):
Interest expense, net(31,329)(30,580)(94,203)(87,600)
Gain on divestitures1,809 — 38,953 — 
Loss on extinguishment and modification of debt(389)— (15,068)— 
Other income (expense), net28 (1,351)105 (193)
Total other expense, net(29,881)(31,931)(70,213)(87,793)
Loss before income taxes
(14,475)(31,845)(4,091)(100,619)
Income tax expense— 161 2,151 904 
Net loss
(14,475)(32,006)(6,242)(101,523)
Less: net loss attributable to noncontrolling interests
(6,098)(14,377)(1,886)(45,865)
Net loss attributable to Baldwin
$(8,377)$(17,629)$(4,356)$(55,658)
Comprehensive loss
$(14,475)$(32,006)$(6,242)$(101,523)
Comprehensive loss attributable to noncontrolling interests
(6,098)(14,377)(1,886)(45,865)
Comprehensive loss attributable to Baldwin
(8,377)(17,629)(4,356)(55,658)
Basic and diluted loss per share
$(0.13)$(0.29)$(0.07)$(0.93)
Basic and diluted weighted-average shares of Class A common stock outstanding64,011,51560,549,08063,001,12559,791,435

5



THE BALDWIN INSURANCE GROUP, INC.
Condensed Consolidated Balance Sheets
(Unaudited)
(in thousands, except share and per share data)September 30, 2024December 31, 2023
Assets
Current assets:
Cash and cash equivalents$181,759 $116,209 
Restricted cash162,957 104,824 
Premiums, commissions and fees receivable, net656,111 627,791 
Prepaid expenses and other current assets13,454 12,730 
Assets held for sale— 64,351 
Total current assets1,014,281 925,905 
Property and equipment, net21,263 22,713 
Right-of-use assets74,960 85,473 
Other assets47,356 38,134 
Intangible assets, net968,811 1,017,343 
Goodwill1,412,369 1,412,369 
Total assets$3,539,040 $3,501,937 
Liabilities, Mezzanine Equity and Stockholders Equity
Current liabilities:
Premiums payable to insurance companies$589,157 $555,569 
Producer commissions payable71,179 64,304 
Accrued expenses and other current liabilities164,302 152,954 
Related party notes payable5,635 1,525 
Current portion of contingent earnout liabilities201,281 215,157 
Liabilities held for sale— 43,931 
Total current liabilities1,031,554 1,033,440 
Revolving line of credit— 341,000 
Long-term debt, less current portion1,399,010 968,183 
Contingent earnout liabilities, less current portion2,509 61,310 
Operating lease liabilities, less current portion69,235 78,999 
Other liabilities123 123 
Total liabilities2,502,431 2,483,055 
Commitments and contingencies
Mezzanine equity:
Redeemable noncontrolling interest375 394 
Stockholders’ equity:
Class A common stock, par value $0.01 per share, 300,000,000 shares authorized; 67,536,347 and 64,133,950 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
675 641 
Class B common stock, par value $0.0001 per share, 100,000,000 shares authorized; 50,013,563 and 52,422,494 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively
Additional paid-in capital785,931 746,671 
Accumulated deficit(191,261)(186,905)
Total stockholders’ equity attributable to Baldwin595,350 560,412 
Noncontrolling interest440,884 458,076 
Total stockholders’ equity1,036,234 1,018,488 
Total liabilities, mezzanine equity and stockholders’ equity$3,539,040 $3,501,937 
6



THE BALDWIN INSURANCE GROUP, INC.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
For the Nine Months
 Ended September 30,
(in thousands)20242023
Cash flows from operating activities:
Net loss$(6,242)$(101,523)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
80,953 73,755 
Change in fair value of contingent consideration17,276 55,065 
Share-based compensation expense46,764 46,637 
Payment of contingent earnout consideration in excess of purchase price accrual(21,145)(22,639)
Gain on divestitures(38,953)— 
Amortization of deferred financing costs4,419 3,577 
Loss on extinguishment of debt1,034 — 
Loss on interest rate caps244 489 
Other loss346 797 
Changes in operating assets and liabilities:
Premiums, commissions and fees receivable, net(27,777)(63,367)
Prepaid expenses and other current assets(7,980)(6,294)
Right-of-use assets12,562 7,671 
Accounts payable, accrued expenses and other current liabilities35,395 32,793 
Operating lease liabilities(11,188)(4,162)
Net cash provided by operating activities85,708 22,799 
Cash flows from investing activities:
Proceeds from divestitures, net of cash transferred56,977 — 
Capital expenditures(28,897)(14,157)
Investments in and loans for business ventures(3,703)(673)
Proceeds from repayment of related party loans1,500 — 
Cash consideration paid for asset acquisitions(268)(2,118)
Net cash provided by (used in) investing activities25,609 (16,948)
Cash flows from financing activities:
Payment of contingent earnout consideration up to amount of purchase price accrual(64,698)(26,808)
Proceeds from revolving line of credit
95,000 88,000 
Payments on revolving line of credit(436,000)(269,000)
Proceeds from refinancing of long-term debt1,440,000 170,000 
Payments relating to extinguishment and modification of long-term debt(996,177)— 
Payments on long-term debt
(4,661)(6,815)
Payments of deferred financing costs(17,988)(4,447)
Proceeds from the settlement of interest rate caps2,300 7,893 
Tax distributions to Baldwin Holdings LLC members(11,076)(408)
Distributions to variable interest entities(264)(385)
Proceeds from repayment of stockholder notes receivable— 42 
Net cash provided by (used in) financing activities6,436 (41,928)
Net increase (decrease) in cash and cash equivalents and restricted cash117,753 (36,077)
Cash and cash equivalents and restricted cash at beginning of period
226,963 230,471 
Cash and cash equivalents and restricted cash at end of period$344,716 $194,394 
7



NON-GAAP FINANCIAL MEASURES
Adjusted EBITDA, adjusted EBITDA margin, organic revenue, organic revenue growth, adjusted net income, adjusted diluted earnings per share (“EPS”), pro forma revenue, pro forma adjusted EBITDA, pro forma adjusted EBITDA margin and adjusted net cash provided by operating activities (“adjusted free cash flow”) are not measures of financial performance under GAAP and should not be considered substitutes for GAAP measures, including commissions and fees (for organic revenue and organic revenue growth), revenues (for pro forma revenue), net income (loss) (for adjusted EBITDA, adjusted EBITDA margin, pro forma adjusted EBITDA and pro forma adjusted EBITDA margin), net income (loss) attributable to Baldwin (for adjusted net income), diluted earnings (loss) per share (for adjusted diluted EPS) or net cash provided by (used in) operating activities (for adjusted free cash flow), which we consider to be the most directly comparable GAAP measures. These non-GAAP financial measures have limitations as analytical tools, and when assessing our operating performance, you should not consider these non-GAAP financial measures in isolation or as substitutes for commissions and fees, net income (loss), net income (loss) attributable to Baldwin, diluted earnings (loss) per share, net cash provided by (used in) operating activities or other consolidated income statement data prepared in accordance with GAAP. Other companies in our industry may define or calculate these non-GAAP financial measures differently than we do, and accordingly, these measures may not be comparable to similarly titled measures used by other companies.
We define adjusted EBITDA as net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related Partnership and integration expenses, severance, and certain non-recurring items, including those related to raising capital. We believe that adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.
Adjusted EBITDA margin is adjusted EBITDA divided by total revenue. Adjusted EBITDA margin is a key metric used by management and our board of directors to assess our financial performance. We believe that adjusted EBITDA margin is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that adjusted EBITDA margin is helpful in measuring profitability of operations on a consolidated level.
Adjusted EBITDA and adjusted EBITDA margin have important limitations as analytical tools. For example, adjusted EBITDA and adjusted EBITDA margin:
do not reflect any cash capital expenditure requirements for the assets being depreciated and amortized that may have to be replaced in the future;
do not reflect changes in, or cash requirements for, our working capital needs;
do not reflect the impact of certain cash charges resulting from matters we consider not to be indicative of our ongoing operations;
do not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our debt;
do not reflect share-based compensation expense and other non-cash charges; and
exclude certain tax payments that may represent a reduction in cash available to us.
8



We calculate organic revenue based on commissions and fees for the relevant period by excluding (i) the first twelve months of commissions and fees generated from new Partners and (ii) commissions and fees from divestitures. Organic revenue growth is the change in organic revenue period-to-period, with prior period results adjusted to (i) include commissions and fees that were excluded from organic revenue in the prior period because the relevant Partners had not yet reached the twelve-month owned mark, but which have reached the twelve-month owned mark in the current period, and (ii) exclude commissions and fees related to divestitures from organic revenue. For example, commissions and fees from a Partner acquired on June 1, 2023 are excluded from organic revenue for 2023. However, after June 1, 2024, results from June 1, 2023 to December 31, 2023 for such Partners are compared to results from June 1, 2024 to December 31, 2024 for purposes of calculating organic revenue growth in 2024. Organic revenue growth is a key metric used by management and our board of directors to assess our financial performance. We believe that organic revenue and organic revenue growth are appropriate measures of operating performance as they allow investors to measure, analyze and compare growth in a meaningful and consistent manner.
We define adjusted net income as net income (loss) attributable to Baldwin adjusted for depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related Partnership and integration expenses, severance, and certain non-recurring costs that, in the opinion of management, significantly affect the period-over-period assessment of operating results, and the related tax effect of those adjustments. We believe that adjusted net income is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to business performance.
Adjusted diluted EPS measures our per share earnings excluding certain expenses as discussed above for adjusted net income and assuming all shares of Class B common stock were exchanged for Class A common stock on a one-for-one basis. Adjusted diluted EPS is calculated as adjusted net income divided by adjusted diluted weighted-average shares outstanding. We believe adjusted diluted EPS is useful to investors because it enables them to better evaluate per share operating performance across reporting periods.
The pro forma information presented herein removes the effects of 2024 divestitures for all periods in 2024 and 2023 as if the divestitures had occurred on January 1, 2024 and January 1, 2023, respectively. Pro forma revenue reflects GAAP revenues less revenue derived from business divestitures that occurred during 2024.
Pro forma net income (loss) reflects GAAP net income (loss) less net income derived from business divestitures that occurred during 2024, including the gain on divestitures. We define Pro forma adjusted EBITDA as pro forma net income (loss) before interest, taxes, depreciation, amortization, change in fair value of contingent consideration and certain items of income and expense, including share-based compensation expense, transaction-related Partnership and integration expenses, severance, and certain non-recurring costs, including those related to raising capital, after removing the effect of divestitures that occurred during 2024. We believe that pro forma adjusted EBITDA is an appropriate measure of operating performance because it eliminates the impact of income and expenses that do not relate to ongoing business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance.
9



Pro forma adjusted EBITDA margin is pro forma adjusted EBITDA divided by pro forma revenue. Pro forma adjusted EBITDA margin is a key metric used by management and our board of directors to assess our ongoing business financial performance. We believe that pro forma adjusted EBITDA margin is an appropriate measure of operating performance because it eliminates the impact of expenses that do not relate to ongoing business performance, and that the presentation of this measure enhances an investor’s understanding of our financial performance. We believe that pro forma adjusted EBITDA margin is helpful in measuring profitability of operations on a consolidated level.
We calculate adjusted free cash flow because we hold fiduciary cash designated for our Insurance Company Partners on behalf of our Clients and incur substantial earnout liabilities in conjunction with our Partnership strategy. Adjusted free cash flow is calculated as net cash provided by (used in) operating activities excluding the impact of: (i) the change in premiums, commissions and fees receivable, net; (ii) the change in accounts payable, accrued expenses and other current liabilities; and (iii) the payment of contingent earnout consideration in excess of purchase price accrual. We believe that adjusted free cash flow is an important financial measure for use in evaluating financial performance because it measures our ability to generate additional cash from our business operations.
Reconciliation of guidance regarding adjusted EBITDA, organic revenue growth, adjusted diluted EPS and adjusted free cash flow to the most directly comparable GAAP measures is not available without unreasonable efforts on a forward-looking basis due to the high variability, complexity, and low visibility with respect to commissions and fees, net income (loss), diluted earnings (loss) per share or other consolidated income statement data prepared in accordance with GAAP. The Company is currently unable to predict with a reasonable degree of certainty the type and extent of items that would be expected to impact these GAAP financial measures for these periods. The unavailable information could have a significant impact on the non-GAAP measures.
10



Adjusted EBITDA and Adjusted EBITDA Margin
The following table reconciles adjusted EBITDA and adjusted EBITDA margin to net loss, which we consider to be the most directly comparable GAAP financial measure:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except percentages)2024202320242023
Revenues$338,938 $306,270 $1,059,145 $933,907 
Net loss
$(14,475)$(32,006)$(6,242)$(101,523)
Adjustments to net loss:
Interest expense, net31,329 30,580 94,203 87,600 
Amortization expense26,899 23,183 76,334 69,505 
Share-based compensation17,949 14,598 46,764 46,637 
Gain on divestitures(1,809)— (38,953)— 
Change in fair value of contingent consideration(952)13,914 17,276 55,065 
Loss on extinguishment and modification of debt389 — 15,068 — 
Colleague earnout incentives4,327 — 10,706 — 
Transaction-related Partnership and integration expenses2,047 3,774 9,042 18,007 
Depreciation expense1,557 1,453 4,619 4,250 
Severance678 875 3,554 3,373 
Income and other taxes82 161 3,300 904 
Loss on interest rate caps84 818 244 489 
Other(1)
4,646 6,659 13,410 20,289 
Adjusted EBITDA$72,751 $64,009 $249,325 $204,596 
Adjusted EBITDA margin21 %21 %24 %22 %
__________
(1)    Other addbacks to adjusted EBITDA include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
Organic Revenue and Organic Revenue Growth
The following table reconciles organic revenue and organic revenue growth to commissions and fees, which we consider to be the most directly comparable GAAP financial measure:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except percentages)2024202320242023
Commissions and fees
$335,210 $304,232 $1,050,409 $929,306 
Partnership commissions and fees(1)
— (985)— (44,696)
Organic revenue$335,210 $303,247 $1,050,409 $884,610 
Organic revenue growth(2)
$40,672 $47,523 $144,844 $150,471 
Organic revenue growth %(2)
14 %19 %16 %20 %
__________
(1)    Includes the first twelve months of such commissions and fees generated from newly acquired Partners.
(2)    Organic revenue for the three and nine months ended September 30, 2023 used to calculate organic revenue growth for the three and nine months ended September 30, 2024 was $294.5 million and $905.6 million, respectively, which is adjusted to exclude commissions and fees from divestitures that occurred during 2024.
11



Adjusted Net Income and Adjusted Diluted EPS
The following table reconciles adjusted net income to net loss attributable to Baldwin and reconciles adjusted diluted EPS to diluted loss per share, which we consider to be the most directly comparable GAAP financial measures:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except per share data)2024202320242023
Net loss attributable to Baldwin
$(8,377)$(17,629)$(4,356)$(55,658)
Net loss attributable to noncontrolling interests(6,098)(14,377)(1,886)(45,865)
Amortization expense26,899 23,183 76,334 69,505 
Share-based compensation17,949 14,598 46,764 46,637 
Gain on divestitures(1,809)— (38,953)— 
Change in fair value of contingent consideration(952)13,914 17,276 55,065 
Loss on extinguishment and modification of debt389 — 15,068 — 
Colleague earnout incentives4,327 — 10,706 — 
Transaction-related Partnership and integration expenses2,047 3,774 9,042 18,007 
Depreciation1,557 1,453 4,619 4,250 
Amortization of deferred financing costs1,422 1,244 4,419 3,577 
Severance678 875 3,554 3,373 
Loss on interest rate caps, net of cash settlements84 3,771 2,544 8,382 
Income tax expense— — 2,151 — 
Other(1)
4,646 6,659 13,410 20,289 
Adjusted pre-tax income42,762 37,465 160,692 127,562 
Adjusted income taxes(2)
4,234 3,709 15,909 12,629 
Adjusted net income$38,528 $33,756 $144,783 $114,933 
Weighted-average shares of Class A common stock outstanding - diluted64,012 60,549 63,001 59,791 
Dilutive weighted-average shares of Class A common stock4,014 3,941 3,570 3,931 
Exchange of Class B common stock(3)
50,490 52,862 51,234 53,367 
Adjusted diluted weighted-average shares outstanding118,516 117,352 117,805 117,089 
Adjusted diluted EPS$0.33 $0.29 $1.23 $0.98 
Diluted loss per share
$(0.13)$(0.29)$(0.07)$(0.93)
Effect of exchange of Class B common stock and net loss attributable to noncontrolling interests per share
0.01 0.02 0.02 0.06 
Other adjustments to loss per share
0.49 0.59 1.42 1.96 
Adjusted income taxes per share(0.04)(0.03)(0.14)(0.11)
Adjusted diluted EPS$0.33 $0.29 $1.23 $0.98 
___________
(1)    Other addbacks to adjusted net income include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
(2)    Represents corporate income taxes at an assumed effective tax rate of 9.9% applied to adjusted pre-tax income.
(3)    Assumes the full exchange of Class B common stock for Class A common stock pursuant to the Amended LLC Agreement.
12



Pro Forma Adjusted EBITDA and Pro Forma Adjusted EBITDA Margin
The following table reconciles pro forma revenue to revenues and reconciles pro forma adjusted EBITDA and pro forma adjusted EBITDA margin to net loss, which we consider to be the most directly comparable GAAP financial measures:
For the Three Months
 Ended September 30,
For the Nine Months
 Ended September 30,
(in thousands, except percentages)2024202320242023
Revenues$338,938 $306,270 $1,059,145 $933,907 
Less revenue from 2024 divestitures(1)
— (9,823)(6,260)(27,130)
Pro forma revenue$338,938 $296,447 $1,052,885 $906,777 
Net loss
$(14,475)$(32,006)$(6,242)$(101,523)
Less net income from 2024 divestitures(2)
(1,809)(1,798)(39,264)(3,194)
Pro forma net loss(16,284)(33,804)(45,506)(104,717)
Adjustments to pro forma net loss:
Interest expense, net31,329 30,580 94,203 87,600 
Amortization expense26,899 22,705 76,334 68,077 
Share-based compensation17,949 14,598 46,764 46,637 
Change in fair value of contingent consideration(952)13,914 17,276 55,043 
Loss on extinguishment and modification of debt389 — 15,068 — 
Colleague earnout incentives4,327 — 10,706 — 
Transaction-related Partnership and integration expenses2,047 3,774 7,992 18,007 
Depreciation expense1,557 1,441 4,619 4,214 
Severance678 814 3,527 3,130 
Income and other taxes82 161 3,300 904 
Loss on interest rate caps84 818 244 489 
Other(3)
4,646 6,657 13,201 20,283 
Pro forma adjusted EBITDA$72,751 $61,658 $247,728 $199,667 
Pro forma adjusted EBITDA margin21 %21 %24 %22 %
___________
(1)    The adjustments exclude revenue from 2024 divestitures for all periods in 2024 and 2023 as if the divestitures had occurred on January 1, 2024 and January 1, 2023, respectively.
(2)    The adjustments exclude net income from 2024 divestitures, including the gain on divestitures, for all periods in 2024 and 2023 as if the divestitures had occurred on January 1, 2024 and January 1, 2023, respectively.
(3)    Other addbacks to pro forma adjusted EBITDA include certain expenses that are considered to be non-recurring or non-operational, including certain recruiting costs, professional fees, litigation costs and bonuses.
Adjusted Net Cash Provided by Operating Activities (“Adjusted Free Cash Flow”)
The following table reconciles adjusted free cash flow to net cash provided by operating activities, which we consider to be the most directly comparable GAAP financial measure:
For the Nine Months
 Ended September 30,
(in thousands)20242023
Net cash provided by operating activities$85,708 $22,799 
Adjustments to net cash provided by operating activities:
Change in premiums, commissions and fees receivable, net27,777 63,367 
Change in accounts payable, accrued expenses and other current liabilities(35,395)(32,793)
Payment of contingent earnout consideration in excess of purchase price accrual21,145 22,639 
Adjusted free cash flow(1)
$99,235 $76,012 
___________
(1)    Without the impact of one-time, third-party refinancing costs of $14.0 million incurred during 2024, adjusted free cash flow would have expanded 49% year-over-year to $113.3 million for the nine months ended September 30, 2024.
13



COMMONLY USED DEFINED TERMS
The following terms have the following meanings throughout this press release unless the context indicates or requires otherwise:
Amended LLC AgreementThird Amended and Restated Limited Liability Company Agreement of The Baldwin Insurance Group Holdings, LLC (formerly Baldwin Risk Partners, LLC), as amended
ClientsOur insureds
ColleaguesOur employees
GAAPAccounting principles generally accepted in the United States of America
Insurance Company PartnersInsurance companies with which we have a contractual relationship
PartnersCompanies that we have acquired, or in the case of asset acquisitions, the producers
PartnershipsStrategic acquisitions made by the Company
SECU.S. Securities and Exchange Commission
14

v3.24.3
DEI Document
Nov. 04, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001781755
Document Type 8-K
Document Period End Date Nov. 04, 2024
Entity Registrant Name The Baldwin Insurance Group, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39095
Entity Tax Identification Number 61-1937225
Entity Address, Address Line One 4211 W. Boy Scout Blvd.
Entity Address, Address Line Two Suite 800
Entity Address, City or Town Tampa
Entity Address, State or Province FL
Entity Address, Postal Zip Code 33607
City Area Code 866
Local Phone Number 279-0698
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Class A Common Stock, par value $0.01 per share
Trading Symbol BWIN
Security Exchange Name NASDAQ
Entity Emerging Growth Company false

Baldwin Insurance (NASDAQ:BWIN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024 Plus de graphiques de la Bourse Baldwin Insurance
Baldwin Insurance (NASDAQ:BWIN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024 Plus de graphiques de la Bourse Baldwin Insurance